- cafead   Apr 12, 2023 at 11:32: AM
via The modification of an existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of RSV antibody Beyfortus (nirsevimab) and 'enhanced agility' in the US market.
article source
article source